Drug Trial Radar · NCT02999178
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Last checked: Nov 20, 2026Latest source record: May 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
663
Actual
Start
Jan 17, 2017
Primary completion
Apr 23, 2019
Study completion Aug 12, 2019
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Dec 21, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the current study is to investigate the efficacy and safety of nintedanib over 52 weeks in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) defined as patients who present with features of diffuse fibrosing lung disease of \>10% extent on high-resolution computed tomography (HRCT) and whose lung function and respiratory symptoms or chest imaging have worsened despite treatment with unapproved medications used in clinical practice to treat ILD. There is currently no efficacious treatment available for PF-ILD. Based on its efficacy and safety in Idiopathic Pulmonary Fibrosis (IPF), it is anticipated that Nintedanib will be a new treatment option for patients with PF-ILD.
Conditions
- Lung Diseases, Interstitial
Interventions
NintedanibDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annual Rate of Decline in Forced Vital Capacity - Overall PopulationTime frame: Baseline, 2, 4, 6, 12, 24, 36, 52 weeks after first drug intake (planned post-baseline visits)
- Annual Rate of Decline in Forced Vital Capacity - Participants With HRCT Fibrotic Pattern=UIP-like Fibrotic Pattern OnlyTime frame: Baseline, 2, 4, 6, 12, 24, 36, 52 weeks after first drug intake (planned post-baseline visits)
Locations
153 sites in 15 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Cedars-Sinai Medical Center
Los Angeles, California
University of California Los Angeles
Los Angeles, California
University of California Davis
Sacramento, California
University of California San Francisco
San Francisco, California
National Jewish Health
Denver, Colorado
Pulmonary and Sleep Specialists
Danbury, Connecticut
Yale University School of Medicine
New Haven, Connecticut
Pulmonary and Sleep of Tampa Bay
Brandon, Florida
University of Florida College of Medicine
Jacksonville, Florida
University of Miami
Miami, Florida
Emory University
Atlanta, Georgia
Northwestern University
Chicago, Illinois
University of Chicago
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky Medical Center
Lexington, Kentucky
University of Maryland School of Medicine
Baltimore, Maryland
Johns Hopkins Hospital
Baltimore, Maryland
Pulmonary and Critical Care Associates of Baltimore
Towson, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Pulmonary and Critical Care Medicine
Ann Arbor, Michigan
Henry Ford Health System
Detroit, Michigan
Spectrum Health
Grand Rapids, Michigan
University of Minnesota Masonic Cancer Center
Minneapolis, Minnesota
Mayo Clinic, Rochester
Rochester, Minnesota
The Lung Research Center, LLC
Chesterfield, Missouri
Creighton University
Omaha, Nebraska
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Icahn School of Medicine at Mount Sinai
New York, New York
Columbia University Medical Center-New York Presbyterian Hospital
New York, New York
NewYork-Presbyterian/Weill Cornell Medical Center
New York, New York
Duke University Medical Center
Durham, North Carolina
Southeastern Research Center
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
The Oregon Clinic
Portland, Oregon
The Oregon Clinic
Portland, Oregon
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania
Showing 40 of 153 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.